N

Novo Nordisk Ltd

45591 employees

Novo Nordisk is a healthcare company that treats diabetes, chronic diseases, and endocrine disorders.

Investor insights

Sectors invested in

Biotechnology10
Health Care5
Pharmaceutical4
Diabetes3
Therapeutics3
Medical Device2
Medical2
the iLet Bionic Pancreas2
bioprinting1
Digital Health1
mHealth1
Real World Data1
Remote Care1
Diabetes Management1
Health Technology1
Chronic Condition Management1
Mobile Healthcare1
Health Data Management1
Mobile Apps1
Remote Patient Monitoring1

Funding rounds participated in

$15M sweet spot round size

Most of their 12 investments are in rounds between $5M and $25M

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Medical
Rare Diseases
Pharmaceutical
Diabetes
Insulin
obesity
Pharmaceuticals

Date founded

1923

Investments made

A

Aspect Biosystems raised undisclosed on April 12, 2023

Investors: Novo Nordisk Ltd

T

The Sabi raised $164K on April 6, 2023

Investors: Bergdorf Goodman and Novo Nordisk Ltd

V

Ventus Therapeutics raised $70M on September 29, 2022

Investors: Novo Nordisk Ltd

B

Beta Bionics raised $57M on February 17, 2022

Investors: Soleus Capital Management, L.P., Pura Vida Investments, LifeSci Venture Partners, Eventide Asset Management, RTW Investments, LP, Farallon Capital Management, Perceptive Advisors and Novo Nordisk Ltd

G

Glooko AB raised $30M on March 16, 2021

Investors: Canaan, Mayo Clinic, Center for Innovation, Georgian Partners, Omnipod® for HCPs, Health Catalyst Capital Management LLC and Novo Nordisk Ltd

S

Sundew ApS raised $1.7M on September 24, 2020

Investors: StartLife, BioInnovation Institute and Novo Nordisk Ltd

I

IO Biotech raised $12M on January 5, 2016

Investors: Lundbeckfonden / Lundbeck Foundation and Novo Nordisk Ltd

B

Beta Bionics raised $5M on December 31, 2015

Investors: Novo Nordisk Ltd

O

Osprey Pharmaceuticals USA, Inc. raised $11M on September 3, 2008

Investors: -, Western Technology, Yasuda Enteprise Development Co. Ltd and Novo Nordisk Ltd

X

Xencor raised $15M on October 25, 2007

Investors: Merlin Nexus and Novo Nordisk Ltd

FAQ